Svennilson Peter Buys NGM Biopharmaceuticals Inc, Revolution Medicines Inc, RAPT Therapeutics Inc, Sells Arcus Biosciences Inc, Gritstone Oncology Inc

Aug 19, 2020

Seattle, WA, based Investment company Svennilson Peter (Current Portfolio) buys NGM Biopharmaceuticals Inc, Revolution Medicines Inc, RAPT Therapeutics Inc, ORIC Pharmaceuticals Inc, sells Arcus Biosciences Inc, Gritstone Oncology Inc during the 3-months ended 2020Q2, according to the most recent filings of the investment company, Svennilson Peter. As of 2020Q2, Svennilson Peter owns 7 stocks with a total value of $1.2 billion. These are the details of the buys and sells.

New Purchases: NGM, RVMD, RAPT, ORIC,
Reduced Positions: RCUS, GRTS,

For the details of Svennilson Peter's stock buys and sells, go to https://www.gurufocus.com/guru/svennilson+peter/current-portfolio/portfolio

These are the top 5 holdings of Svennilson Peter

NGM Biopharmaceuticals Inc (NGM) - 17,706,978 shares, 29.23% of the total portfolio. New Position
Revolution Medicines Inc (RVMD) - 7,977,384 shares, 21.06% of the total portfolio. New Position
RAPT Therapeutics Inc (RAPT) - 6,777,151 shares, 16.45% of the total portfolio. New Position
Constellation Pharmaceuticals Inc (CNST) - 6,051,376 shares, 15.21% of the total portfolio.
ORIC Pharmaceuticals Inc (ORIC) - 4,768,181 shares, 13.45% of the total portfolio. New Position

New Purchase: NGM Biopharmaceuticals Inc (NGM)

Svennilson Peter initiated holding in NGM Biopharmaceuticals Inc. The purchase prices were between $11.97 and $23.47, with an estimated average price of $18.97. The stock is now traded at around $18.46. The impact to a portfolio due to this purchase was 29.23%. The holding were 17,706,978 shares as of .

New Purchase: Revolution Medicines Inc (RVMD)

Svennilson Peter initiated holding in Revolution Medicines Inc. The purchase prices were between $19.65 and $39.34, with an estimated average price of $31.21. The stock is now traded at around $26.28. The impact to a portfolio due to this purchase was 21.06%. The holding were 7,977,384 shares as of .

New Purchase: RAPT Therapeutics Inc (RAPT)

Svennilson Peter initiated holding in RAPT Therapeutics Inc. The purchase prices were between $14.16 and $32.85, with an estimated average price of $19.31. The stock is now traded at around $25.91. The impact to a portfolio due to this purchase was 16.45%. The holding were 6,777,151 shares as of .

New Purchase: ORIC Pharmaceuticals Inc (ORIC)

Svennilson Peter initiated holding in ORIC Pharmaceuticals Inc. The purchase prices were between $25.68 and $38.12, with an estimated average price of $31.84. The stock is now traded at around $25.34. The impact to a portfolio due to this purchase was 13.45%. The holding were 4,768,181 shares as of .

Here is the complete portfolio of Svennilson Peter. Also check out:

1. Svennilson Peter's Undervalued Stocks
2. Svennilson Peter's Top Growth Companies, and
3. Svennilson Peter's High Yield stocks
4. Stocks that Svennilson Peter keeps buying

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.